Table 2 ECG characteristics from A/A mice treated with continuous epinephrine injection and overexpression APOE

From: Dysregulated RBM24 phosphorylation impairs APOE translation underlying psychological stress-induced cardiovascular disease

 

OE-APOE

E

E + OE-APOE

Time (Days)

0

1

3

0

1

3

0

1

3

HR (bpm)

452 ± 28

400 ± 13

485 ± 36

432 ± 28

539 ± 33

481 ± 75

474 ± 24

496 ± 22

491 ± 31

PR (msec)

40.4 ± 3.9

46.3 ± 4.8

43.8 ± 3.5

42.3 ± 2.1

44.4 ± 3.2

48.5 ± 11

46.2 ± 2.7

48.6 ± 4.41

49 ± 5.2

QT (msec)

29.6 ± 3.1

29.9 ± 2.9

30.4 ± 1.39

29.9 ± 1.2

28.2 ± 2.9

36.7 ± 6.2

31.3  ± 2.6

31.3  ± 2.6

33.8  ± 1.6

QTc

28.3 ± 1.9

24.4 ± 2.7

27.2 ± 1.25

25.3 ± 1.0

26.7 ± 3.2

32.3 ± 2.7

28.6 ± 1.2

28.5 ± 3.0

30.5 ± 2.1

QRS (msec)

15.2 ± 2.1

13.0 ± 0.6

12.4 ± 1.6

12.8 ± 1.07

12.1 ± 0.19

12.5 ± 1.30

12.8 ± 1.46

12.5 ± 0.62

12.5 ± 0.75

AmpP (mv)

0.11 ± 0.01

0.08 ± 0.01

0.08 ± 0.01

0.09 ± 0.01

0.07 ± 0.01

0.06 ± 0.01

0.08 ± 0.02

0.09 ± 0.01

0.09 ± 0.03

AmpQ (mv)

−0 ± 0.01

−0 ± 0.01

−0 ± 0.01

−0 ± 0.01

−0 ± 0.01

−0 ± 0.01

−0 ± 0.01

−0 ± 0.01

−0 ± 0.01

AmpR (mv)

0.92 ± 0.06

0.86 ± 0.16

0.89 ± 0.16

0.95 ± 0.15

0.80 ± 0.11

0.88 ± 0.13

0.94 ± 0.16

0.78 ± 0.13

0.78 ± 0.09

AmpS (mv)

−0.18 ± 0.05

−0.08 ± 0.01

−007  ± 0.01

−0.06 ± 0.08

−0.07 ± 0.02

−0.06 ± 0.02

−0.06 ± 0.02

−0.04 ± 0.01

−0.05 ± 0.01

  1. HR heart rate, PR PR interval, QT QT interval, QTc QT interval corrected for HR, QRS QRS interval, AmpP amplitude of P wave, AmpQ amplitude of Q wave, AmpS amplitude of S wave.